This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Intellectual Property

Nov. 8, 2021

Biden administration emphasizes 'quality; in patent proposals

This past summer, President Joe Biden issued an Executive Order on Promoting Competition in the American Economy. This executive order focused on patent quality and curbing alleged misuses of the patent system, in particular with respect to generic drug and biosimilar availability and drug pricing.

Sarah Geers

Partner
Jones Day

Sarah is a partner in Jones Day's Intellectual Property practice in the firm's New York office. Ms. Geers represents pharmaceutical and biotechnology clients in intellectual property litigation in a variety of venues, including in district court, arbitration, and at PTAB. Her practice spans Hatch-Waxman and other patent enforcement actions, inter partes review proceedings, trade secret and misappropriation actions, and patent prosecution strategy and other counseling matters.

See more...

Matt Johnson

Partner
Jones Day

Matt is a partner in Jones' Day's Intellectual Property practice in the firm's Pittsburgh office. Mr. Johnson is one of the firm's primary contacts on practice before the PTAB. Currently co-chairing Jones Day's PTAB subpractice and involved in proceedings at the board since the first day of their availability in September 2012, he regularly represents clients as both petitioners and patent owners at the board. Mr. Johnson further works as an advocate for clients in appeals from board proceedings at the Federal Circuit

See more...

This past summer, President Joe Biden issued an Executive Order on Promoting Competition in the American Economy. This executive order focused on patent quality and curbing alleged misuses of the patent system, in particular with respect to generic drug and biosimilar availability and drug pricing. The Biden administration's focus on improving the patent system has continued into the fall. In late October, President Biden announced a long-awaited nomination for under...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up